PRF Technologies PRFX
NASDAQ PRFX
$1.00 0.00 (-0.29%)
At close: Aug 21, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Income towards Parent Company (2020 - 2024)

PRF Technologies' (PRFX) quarterly Income towards Parent Company came in at -$7.6 million in Q2 2024, down 204.12% YoY from $7.3 million in Q3 2023, and down 30.63% on a QoQ basis from -$5.8 million in Q1 2024.

PRF Technologies (PRFX) Income towards Parent Company (2020 - 2024) Analysis & Trends

PRF Technologies (PRFX) has 5 years of Income towards Parent Company data on file, last reported at -$7.6 million in Q2 2024.

  • Quarterly Income towards Parent Company fell 204.12% year-over-year to -$7.6 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$7.6 million (up 68.54% YoY) and the FY2025 annual result came in at -$5.0 million, up 66.16% from the prior year.
  • Income towards Parent Company declined to -$7.6 million in Q2 2024, from -$5.8 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$132000.0 in Q1 2020 to a low of -$10.7 million in Q4 2023.
  • A 5-year average of -$3.6 million and a median of -$2.3 million in 2021 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2021 — Income towards Parent Company slumped 1606.06% — and 2023, when it surged 31.46%.
  • Tracing PRFX's Income towards Parent Company over 5 years: stood at -$4.2 million in 2020, then plunged by 65.42% to -$6.9 million in 2021, then declined by 28.75% to -$8.9 million in 2022, then dropped by 21.01% to -$10.7 million in 2023, then climbed by 29.24% to -$7.6 million in 2024.
  • The last three Income towards Parent Company figures came in at -$7.6 million (Q2 2024), -$5.8 million (Q1 2024), and -$10.7 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 PRF Technologies 647,973.00 -3.49 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 -7.60 Mn
Mar 31, 2024 -5.82 Mn
Dec 31, 2023 -10.74 Mn
Sep 30, 2023 -1.60 Mn
Jun 30, 2023 -2.50 Mn
Mar 31, 2023 -2.66 Mn
Dec 31, 2022 -8.88 Mn
Sep 30, 2022 -2.34 Mn
Jun 30, 2022 -2.08 Mn
Mar 31, 2022 -1.91 Mn
Dec 31, 2021 -6.89 Mn
Sep 30, 2021 -2.00 Mn
Jun 30, 2021 -1.88 Mn
Mar 31, 2021 -2.25 Mn
Dec 31, 2020 -4.17 Mn
Sep 30, 2020 -700,000.00
Jun 30, 2020 -148,000.00
Mar 31, 2020 -132,000.00